Crossmark Global Holdings’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-16,474
Closed -$393K – 1282
2024
Q2
$393K Hold
16,474
– – 0.01% 928
2024
Q1
$290K Buy
+16,474
New +$243K 0.01% 1111
2022
Q2
– Sell
-6,976
Closed -$241K – 1281
2022
Q1
$241K Buy
6,976
+1,890
+37% +$61.3K 0.01% 1224
2021
Q4
$253K Buy
+5,086
New +$268K 0.01% 1232

Other funds holding ASPN

Crossmark Global Holdings's ASPN Position: Q3 2024 in Review

Crossmark Global Holdings sold out of Aspen Aerogels (ASPN) in Q3 2024, closing a stake of 16,474 shares — an estimated $393K sold.

Crossmark Global Holdings first reported a position in ASPN in Q4 2021 and held it in 4 quarters. The position peaked at $393K in Q2 2024. 243 funds tracked by Wall St. Rank hold ASPN as of Q3 2024.

  • Crossmark Global Holdings reported no remaining Aspen Aerogels position as of Q3 2024 after selling out during the quarter.
  • Crossmark Global Holdings sold 16,474 Aspen Aerogels shares in Q3 2024, an estimated $393K.
  • Crossmark Global Holdings first reported a position in Aspen Aerogels in Q4 2021 and held it in 4 quarters.
  • Crossmark Global Holdings's Aspen Aerogels position peaked at $393K in Q2 2024.
  • 243 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2024.

Based on Crossmark Global Holdings's 13F filing for Q3 2024, filed 4 Nov 2024.